Symbol
DMAC on Nasdaq
Investment type
Equity / Voting Common Shares, no par value
Latest Disclosed Ownership
7.76M shares
Security Ownership
15%

Trill AB ownership in DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC)

2025-09-04 - Trill AB has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.76M shares of DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC). This represents 15% percent ownership of the company. In their previous filing dated 2025-07-30, TRILL AB had reported owning 6.76M shares, indicating an increase of 14.8% percent.